Literature DB >> 8607170

Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation.

R C Dickson1, S H Caldwell, M B Ishitani, J Y Lau, C J Driscoll, W C Stevenson, C S McCullough, T L Pruett.   

Abstract

Hepatitis C viral recurrence after orthotopic liver transplantation is almost universal. Hepatitis C induced graft failure may occur, but the clinical and histologic profiles are not well defined. The aim of this study was to describe the pattern of early graft failure in patients with recurrent hepatitis C after liver transplantation. Thirty patients with hepatitis C underwent liver transplantation from October 1989 through September 1994. Four patients were excluded because of death (2 patients), graft failure unrelated to hepatitis C (1 patient), and lost to follow-up (1 patient). Hepatitis C recurred in 24 of the 26 remaining patients. In 4 patients with hepatitis C virus recurrence and cholestasis, graft failure developed at 5.25, 11.0, 11.0, and 18.5 months. The medical records and liver biopsies were reviewed. In all 4 patients, a histologic pattern characterized by centrilobular ballooning degeneration developed and progressed to involve more than two-thirds of the lobules. Moderate to severe cholestasis and bridging fibrosis were present in all grafts at explant. Two patients had portal inflammation on 3-month biopsies consistent with viral hepatitis. All patients had mild macrovesicular steatosis, but only 1 patient had significant lymphoid aggregates. No patient had evidence of hepatic artery thrombosis. One patient had potential drug-induced cholestasis. One patient had 3 episodes of rejection that were not believed to contribute to graft loss. All 4 patients developed clinical features of hepatic failure and were retransplanted. Two patients had early recurrence of graft failure. We conclude that a pattern of progressive centrilobular ballooning degeneration, bridging fibrosis, and cholestasis occurs in some patients with hepatitis with early graft failure, similar to fibrosing cholestatic hepatitis seen in some transplant patients with recurrent hepatitis B.

Entities:  

Mesh:

Year:  1996        PMID: 8607170     DOI: 10.1097/00007890-199603150-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case.

Authors:  Takasuke Fukuhara; Kazutoyo Morita; Kazuki Takeishi; Takeo Toshima; Kenji Umeda; Shigeyuki Nagata; Keishi Sugimachi; Toru Ikegami; Tomonobu Gion; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

Review 2.  Living donor liver transplantation to patients with hepatitis C virus cirrhosis.

Authors:  Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

Authors:  Kieron B L Lim; Hamid R Sima; M Isabel Fiel; Viktoriya Khaitova; John T Doucette; Maria Chernyiak; Jawad Ahmad; Nancy Bach; Charissa Chang; Priya Grewal; Leona Kim-Schluger; Lawrence Liu; Joseph Odin; Ponni Perumalswami; Sander S Florman; Thomas D Schiano
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 4.  Management of Post-Liver Transplant Recurrence of Hepatitis C.

Authors:  Justin Taylor; Paula Cox-North; Charles S Landis
Journal:  Drugs       Date:  2016-12       Impact factor: 9.546

Review 5.  Approach to recurrent hepatitis C following liver transplantation.

Authors:  Michael Charlton
Journal:  Curr Gastroenterol Rep       Date:  2007-03

6.  Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival.

Authors:  Jeanne-Marie Giard; Norah A Terrault
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-17       Impact factor: 11.382

7.  Fibrosing cholestatic hepatitis with hepatitis C virus treated by double filtration plasmapheresis and interferon plus ribavirin after liver transplantation.

Authors:  Teruki Miyake; Kojiro Michitaka; Yoshio Tokumoto; Shinya Furukawa; Teruhisa Ueda; Yoshiko Soga; Masanori Abe; Bunzo Matsuura; Taro Nakamura; Taiji Tohyama; Nobuaki Kobayashi; Yoichi Hiasa; Morikazu Onji
Journal:  Clin J Gastroenterol       Date:  2009-01-10

8.  Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation.

Authors:  Allison Mah; Alissa Wright
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

9.  Treatment of Hepatitis C Virus in the Liver Transplant Recipient.

Authors:  Lafaine Grant; Jeffrey S. Crippin
Journal:  Curr Treat Options Gastroenterol       Date:  2003-12

10.  Role of living donor liver transplantation in the treatment of hepatitis C virus infection.

Authors:  Georgios Tsoulfas; Polyxeni Agorastou
Journal:  Hepat Mon       Date:  2011-06       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.